Family Medicine · Oklahoma City, OK
NPI
1134167455
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
13921 N Meridian Ave Ste 100
Oklahoma City, OK, 73134
Phone (405) 752-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$308K
10,234 services
Medicare patients, 2024
677
Average age 69
Drug cost, 2024
$1.8M
13,770 prescriptions
Company payments, 2025
$1,515
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen B Kelly was code 98977 (pulmonary function testing), 2,809 times for 408 patients. In total Stephen B Kelly billed 10,234 services in 88 codes, and Medicare paid $308K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 98977 Pulmonary Function Testing | Office | 2,809 | 408 | $31.69 | $89K |
| 98980 Care Management/Coordination | Office | 2,441 | 382 | $35.33 | $86K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 676 | 124 | $0.08 | $57.12 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 636 | 113 | $0.75 | $477 |
| 99213 Office E&M - Established | Office | 573 | 268 | $52.91 | $30K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 293 | 179 | $126.83 | $37K |
| 98975 Pulmonary | Office | 261 | 258 | $12.85 | $3,354 |
| 99214 Office E&M - Established | Office | 196 | 126 | $85.18 | $17K |
| 96138 Behavioral Health Services | Office | 82 | 82 | $20.74 | $1,701 |
| 96372 Injection Administration | Office | 59 | 37 | $8.13 | $480 |
| 20553 Musculoskeletal | Office | 58 | 43 | $37.14 | $2,154 |
| 20610 Joint Injection | Office | 47 | 29 | $48.38 | $2,274 |
| 36415 Venipuncture Blood Collection | Office | 39 | 37 | $8.00 | $312 |
| 99204 Office E&M - New | Office | 37 | 37 | $110.83 | $4,101 |
| 80053 Clinical Chemistry | Office | 36 | 34 | $9.20 | $331 |
By year: 2022 $518K for 17,897 services; 2023 $237K for 12,645 services; 2024 $308K for 10,234 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 293 | 179 | $126.83 | $37K |
| 36415 Venipuncture Blood Collection | 39 | 37 | $8.00 | $312 |
| 80053 Clinical Chemistry | 36 | 34 | $9.20 | $331 |
| 85025 Blood Count | 35 | 33 | $6.31 | $221 |
| 82306 Clinical Chemistry | 33 | 33 | $23.19 | $765 |
| 84443 Clinical Chemistry | 33 | 31 | $14.46 | $477 |
| 82607 Clinical Chemistry | 32 | 32 | $11.72 | $375 |
| 85651 Clinical Chemistry | 29 | 28 | $3.64 | $105 |
| 82550 Clinical Chemistry | 18 | 18 | $6.38 | $115 |
| 84550 Clinical Chemistry | 15 | 15 | $4.43 | $66.45 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen B Kelly prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,095 prescriptions and refills. In total Stephen B Kelly wrote 13,770 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,095 | 2,095 | 609 | $62K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,573 | 1,573 | 455 | $232K |
| Oxycodone Hcl Generic | 848 | 848 | 211 | $15K |
| Gabapentin Generic | 785 | 941 | 233 | $11K |
| Buprenorphine Hcl Generic | 743 | 750 | 250 | $26K |
| Morphine Sulfate Er Morphine Sulfate | 481 | 481 | 134 | $14K |
| Tizanidine Hcl Generic | 395 | 479 | 104 | $3,775 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 385 | 386 | 120 | $37K |
| Buprenorphine Generic | 367 | 367 | 142 | $94K |
| Belbuca Buprenorphine Hcl | 365 | 365 | 163 | $267K |
| Pregabalin Generic | 352 | 388 | 105 | $5,919 |
| Cyclobenzaprine Hcl Generic | 326 | 366 | 95 | $2,817 |
| Methadone Hcl Generic | 232 | 232 | 63 | $4,078 |
| Trazodone Hcl Generic | 216 | 291 | 58 | $1,290 |
| Morphine Sulfate Generic | 198 | 198 | 55 | $6,100 |
Brand drugs: - claims; generic drugs: 11,949 claims; opioid claims: 7,240.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen B Kelly $1,515 ($1,515 in general payments such as food, travel and fees) from 21 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $333.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 19 | $333 |
| Forte Bio-Pharma LLC | 13 | $206 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $122 |
| Abbvie Inc. ABBV | 6 | $111 |
| Protega Pharmaceutials Inc | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $79.54 |
| Lundbeck LLC | 3 | $76.97 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $62.34 |
| Valinor Pharma, LLC | 3 | $54.43 |
| Pfizer Inc. PFE | 3 | $52.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.